Abstract
We report a rare CD5 positive B cell acute lymphoblastic leukemia (B-ALL) with a review of the clinopathological features and prognosis of previously reported cases in the literature. The aberrant expression of CD 5 antigen is uncommon in B-ALL; the morphological differential diagnosis includes blastic mantle cell lymphoma, denovo CD5+ diffuse large B cell lymphoma and secondary diffuse large cell lymphoma/Richter’s transformation. CD5+ B cell ALL is commonly reported in younger patients (<18 years). Though the expression of T cell antigens is reported to have poor prognosis, the experience with CD5+ B-ALL is limited to draw any firm conclusion regarding its prognosis.
References
Weng XQ, Shen Y, Sheng Y et al (2013) Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia. Blood Cancer J 3:e133
Bene MC, Kaeda JS (2009) How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet. Haematologica 94:1135–1150
Seegmiller AC, Kroft SH, Karandikar NJ, McKenna RW (2009) Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia. Am J Clin Pathol 132:940–949
Hussein S, Gill KZ, Sireci AN et al (2011) Aberrant T-cell antigen expression in B lymphoblastic leukaemia. Br J Haematol 155:449–456
Paraskevas F (2009) Appendix A: clusters of differentiation. In: Greer JP, Foerster J, Rodgers GM et al (eds) Wintrobe’s clinical hematology, vol 2. Lippincot Williams & Wilkins, Philadelphia, pp 2498–2576
Ahmed D, Ahmed TA, Ahmed S, Tipu HN, Wiqar MA (2008) CD5-positive acute lymphoblastic leukemia. J Coll Physicians Surg Pak 18:310–311
Baumgarth N (2011) The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 11:34–46
Craig FE, Foon KA (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111:3941–3967
Subirá D, Roman A, Jiménez-Garófano C et al (1998) Brief report. CD19/CD5 acute lymphoblastic leukemia. Med Pediatr Oncol 31:551–552
Peterson MR, Noskoviak KJ, Newbury R (2007) CD5-positive B-cell acute lymphoblastic leukemia. Pediatr Dev Pathol 10:41–45
Mutreja D, Pati HP, Bansal D, Sharma RK, Jain S (2014) Aberrant immunophenotypic expression of CD5 in a case of B acute lymphoblastic leukemia: a case report. Indian J Hematol Blood Transfus 30:212–214
Thomas DA, O’Brien S, Jorgensen JL et al (2009) Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood 113:6330–6337
Liu L, McGavran L, Lovell MA et al (2004) Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia. Am J Clin Pathol 121:810–815
Conflict of interest
The authors declare that there is no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sreedharanunni, S., Kumar, N. & Khadwal, A. CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature. Indian J Hematol Blood Transfus 32 (Suppl 1), 1–4 (2016). https://doi.org/10.1007/s12288-014-0485-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-014-0485-y